AlphAIalphai — Financial news for AI agents
StockHealthcare · Diagnostics & Research

$XGN

EXAGEN INC.

Price · $XGNvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $XGN in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $XGN in the last 30 days.

Top stories · $XGNMore →
MAY 14·Yahoo FinanceMed

The Exagen Inc. (NASDAQ:XGN) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Exagen Inc. (NASDAQ:XGN) reported strong first-quarter results with revenues exceeding analyst forecasts, leading to lower statutory losses than anticipated. Analysts have consequently updated their forecasts, with a moderate uplift in sentiment regarding loss per share, though the average price target remains steady at US$8.67. Despite the positive adjustments, Exagen's projected revenue growth of 6.3% annually until 2026 is expected to trail the broader industry's 22% annual growth.

APR 27·GlobeNewswire

Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026

Exagen Inc. will release its first-quarter financial results for the period ended March 31, 2026, before the market opens on Monday, May 11, 2026. Following the release, President and CEO John Aballi and CFO Jeff Black will host a conference call to discuss the results. The company, a provider of innovative autoimmune testing, will also make the webcast and a replay available on its investor relations website.

APR 12·Insider Monkey

Does Exagen (XGN)’s 200%+ Upside Potential Make It One of the Best Penny Stocks Set to Explode?

Exagen Inc. (NASDAQ: XGN) is considered one of the best penny stocks to watch, with analysts assigning over 80% "Buy" ratings and a consensus price target of $10, implying a significant 235.01% upside. Despite a recent price target reduction by Craig-Hallum due to lower-than-expected average selling prices, the company reported a 20% year-over-year revenue increase in Q4 2025 and ended the year with $32 million in cash. Exagen, a diagnostics company focusing on autoimmune diseases, is guiding 2026 revenue between $70 million and $73 million, demonstrating a push toward profitable growth.

News on $XGN

All news →